Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NACDS In Brief

This article was originally published in The Tan Sheet

Executive Summary

Perrigo: Private label CoQ10 and fish oil introduced under out-licensed combination-of-matter patent, the firm announces at the NACDS Marketplace in San Diego. Containing 1,000 mg fish oil, 50 mg CoQ10 and 30 IU of vitamin E, the combo allows for once-per-day use, compared to the 2-3 pills-per-day required by other products, Perrigo maintains. Acidophilus Extra Strength capsules, also launching now, feature a tri-layer system designed to prevent deterioration prior to absorption in the body. The exterior shell protects the product when exposed to air, the secondary shell prevents decay due to stomach acid and the third shell is dissolved in the digestive tract, where the ingredients are released, the private labeler says. Sesame Street Multivitamin Gummies, an extension of the children's line launched last year, also are unveiled (1"The Tan Sheet" June 23, 2003, p. 11). On the OTC side, Perrigo introduces Miconazole 3, the equivalent of J&J's market leading three-day yeast infection therapy Monistat-3. Shipping in July, the product offers three pre-filled applicators...
Advertisement

Related Content

Perrigo New Products Include Branded Weight-Loss Supplement, Kid’s Multi
Perrigo New Products Include Branded Weight-Loss Supplement, Kid’s Multi

Topics

Advertisement
UsernamePublicRestriction

Register

PS097044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel